FDA Approved: YUVEZZI — Original Application (Visus Therapeutics, Inc.)

View source ↗

Summary

The FDA approved YUVEZZI, a fixed-dose combination ophthalmic preparation of carbachol and brimonidine tartrate, under an original NDA from Visus Therapeutics, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• YUVEZZI (CARBACHOL AND BRIMONIDINE TARTRATE)

Snippet

ORIG AP for YUVEZZI (CARBACHOL AND BRIMONIDINE TARTRATE)